BioSpace News Archive

Kahn-Sagol-Maccabi (KSM), and Valo Health, Inc. (“Valo”), announced today a first-of-its-kind multiyear collaboration in which Valo and Maccabi KSM Research and Innovation’s Biobank will jointly conduct research leveraging Valo’s Opal Computational Platform™ to identify preventive care and personalized medicine for patients.

RenovoRx, Inc. today announced that Angela Gill Nelms has joined the company as Chief Operating Officer (“COO”).

Vistagen today announced that data highlighting intranasal administration of PH94B, the Company’s first-in-class synthetic investigational pherine nasal spray in Phase 3 development for acute treatment of social anxiety disorder, were presented at Psych Congress in New Orleans on September 18, 2022.

Neogen ® Corporation (NASDAQ: NEOG) announced today that it has released its innovative Veratox ® VIP assay for the detection of cashew, the second assay in Neogen’s new Veratox VIP line of enhanced quantitative ELISA products.

Lantern Pharma Inc. today announced that it will host a virtual key opinion leader (KOL) webinar on Sept. 22, 2022 at 12:00 p.m. ET.

Shockwave Medical, Inc. (NASDAQ: SWAV), has initiated the first-ever prospective coronary intervention study consisting of all female patients – EMPOWER CAD – to determine whether the positive results from earlier coronary IVL studies with the Shockwave C2 Coronary IVL Catheter.

TB Alliance welcomes Kim Schwartz and Rasha Hibri to its Board of Directors. Their expertise will help guide the organization as it continues to advance its research and product delivery agenda.